Canary Speech is a technology company that uses AI-driven vocal digital biomarkers for conversational speech virtual health monitoring.
Canary Speech has raised $4.1M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in January 2025.
Canary Speech's investors include Hackensack Meridian Health, Sorenson Communications, Cortes capital, SMK Corporation.
Canary Speech is headquartered in Provo, United States.
Canary Speech is a technology company that uses AI-driven vocal digital biomarkers for conversational speech virtual health monitoring.
Canary Speech is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Canary Speech — Funding & Investors." VCBacked, January 6, 2025, https://www.vcbacked.co/company/canary-speech. Accessed November 12, 2026.
VCBacked. (2025). Canary Speech — Funding & Investors. Retrieved November 12, 2026, from https://www.vcbacked.co/company/canary-speech
{{cite web |title=Canary Speech — Funding & Investors |url=https://www.vcbacked.co/company/canary-speech |website=VCBacked |access-date=November 12, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at Canary Speech? Request a listing update